Status:
COMPLETED
Trainee Involvement in ERCP Risk Score
Lead Sponsor:
Clinical Hospital Colentina
Collaborating Sponsors:
Policlinico Gemelli, Rome, Italy
Cantacuzino Clinical Hospital, Bucharest, Romania
Conditions:
Bile Duct Diseases
Pancreas Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to evaluate factors associated with an increased risk of procedure related adverse events (including tecnical failure) of endoscopic retrograde cholangiopancreatography procedures (ERCP...
Detailed Description
The study aims to evaluate factors associated with an increased risk of procedure related adverse events (including tecnical failure) of endoscopic retrograde cholangiopancreatography procedures (ERCP...
Eligibility Criteria
Inclusion
- patients undergoing ERCP in the participating centers
- informed consent signed prior to the procedure
Exclusion
- refusal to participate / sign the informed consent
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
1283 Patients enrolled
Trial Details
Trial ID
NCT04341909
Start Date
April 1 2020
End Date
January 1 2022
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Colentina Clinical Hospital
Bucharest, Romania